F. Gary Toback
Corporate Officer/Principal at The University of Chicago
Profile
F.
Gary Toback is a Professor at The University of Chicago since 1985.
He was a Founding Scientist & Consultant at NephRx Corp.
He completed his undergraduate degree at The Trustees of Columbia University in The City of New York and his doctorate at Boston University and New York University.
F. Gary Toback active positions
| Companies | Position | Start |
|---|---|---|
| The University of Chicago | Corporate Officer/Principal | 1984-12-31 |
Former positions of F. Gary Toback
| Companies | Position | End |
|---|---|---|
NephRx Corp.
 NephRx Corp. BiotechnologyHealth Technology NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan. | Chief Tech/Sci/R&D Officer | - |
Training of F. Gary Toback
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| New York University | Doctorate Degree |
| Boston University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
NephRx Corp.
NephRx Corp. BiotechnologyHealth Technology NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan. | Health Technology |
- Stock Market
- Insiders
- F. Gary Toback
